Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No change to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-25T21:05:52.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:52:24.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and a prior revision notice (v3.4.1) along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:46:33.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a government funding lapse notice about NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:00:35.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC metadata, including 'Last Update Submitted that Met QC Criteria' and a new 'Revision: v3.4.0'. The older label variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4') were removed.
    Difference
    0.2%
    Check dated 2026-01-27T22:52:33.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Footer updates include Revision: v3.3.3; removal of the HHS Vulnerability Disclosure link and the older Revision: v3.3.2 reference.
    Difference
    0.1%
    Check dated 2025-12-23T08:38:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.